Wearables Funding Surges, Brain Tech Raises $250M, GRAIL Nears FDA Decision

September 25, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

GRAIL's Galleri cancer blood test moves closer to FDA approval after an advisory panel found benefits outweigh risks, despite a near-split vote on efficacy Wearables draw $4.1B in investment this year, nearing the 2021 peak as Whoop raises $575M and Oura preps a potential $16B public listing Precision Neuroscience closes a $250M Series D, bringing total funding to $430M as its FDA-cleared brain-computer interface moves toward commercial use

Today's episode is brought to you by AIIR — a modern communications and experiential ag...